PGI — Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples Class II

FDA Device Classification

Classification Details

Product Code
PGI
Device Class
Class II
Regulation Number
866.3309
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

For the qualitative detection and differentiation of VZV, HSV1, HSV2- DNA in cutaneous and mucocutaneous lesion samples from symptomatic patients. The assay is not intended for use with cerebral spinal fluid.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K233349abbott molecularAlinity m HSV 1 & 2 / VZVMay 3, 2024
K232286quidel corporationSavanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna InstrumentDecember 20, 2023
K192376diasorin molecularSimplexa VZV Swab Direct, Simplexa VZV Positive Control PackNovember 26, 2019
K180559elitechgroupHSV 1 & 2 ELITe MGB Kit; ELITe InGeniusOctober 29, 2018
K173798diasorin molecularSimplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackMarch 14, 2018
K162451quidel corporationSolana HSV 1+2/VZV AssayNovember 28, 2016
K151906luminex corporationARIES HSV 1&2 Assay Cassettes - Carton of 24 (IVD), ARIES HSV 1&2 Assay ProtocolOctober 6, 2015
K151046meridian bioscienceillumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control July 17, 2015
DEN140004diagnostic hybridsQUIDEL MOLECULAR DIRECT HSV 1 +2/VZV ASSAYMay 13, 2014